Advertisement
Oral forms of medications contain an average of 8.8 inactive ingredients

Average of 8.8 Inactive Ingredients Found in Oral Medications

0
Overall, 92.8 percent of oral solid medications contain at least one potential allergen
Only 1.0 percent of reported cases of spotted fever rickettsioses meet the confirmed case definition

Reported Cases of Spotted Fever Rickettsioses Rarely Confirmed

0
Elevated IgG antibody titer was most common supportive lab evidence for probable cases
An antibacterial envelope can reduce the incidence of major cardiac implantable electronic device infections

ACC: Antibacterial Envelope Can Reduce CIED Infections

0
Incidence of major cardiac implantable electronic device infections significantly lower with envelope
Recommendations have been developed for use of polymyxins

Guidelines Developed for Polymyxin Antibiotic Use

0
Polymyxin B recommended for routine use in invasive infections; colistin preferred for lower UTI
From 2014 to 2017

Physician Burnout Rate Increased From 2014 to 2017

0
Early-career physicians most susceptible to burnout; late-career physicians less vulnerable
The U.S. Environmental Protection Agency proposal to allow use of the antibiotic streptomycin to treat citrus disease should be withdrawn because it poses a risk to human health and the environment

EPA Proposal Will Allow Antibiotic Spraying of Citrus Crops

0
Consumer Reports warns of '26-fold increase in the use of streptomycin in plant agriculture'
For HIV-infected patients

One-Month Regimen Noninferior for Preventing HIV-Related TB

0
One-month rifapentine, isoniazid noninferior to nine months of isoniazid alone
The American Academy of Pediatrics (AAP) plans to advise families to vaccinate children against influenza with either the flu shot or nasal spray vaccine during the 2019 to 2020 flu season

AAP: Nasal Spray Vaccine Against Flu Acceptable in 2019 to 2020

0
Based on current data, AAP Board of Directors says either injection or nasal spray vaccination OK
A short regimen is noninferior to a long regimen for patients with rifampin-resistant tuberculosis that is susceptible to fluoroquinolones and aminoglycosides

Short Regimen Noninferior for Rifampin-Resistant Tuberculosis

0
Short regimen of nine to 11 months noninferior to 20-month regimen following WHO guidelines
The U.S. Food and Drug Administration will temporarily be overseen by the head of the National Cancer Institute when FDA Commissioner Scott Gottlieb

Head of National Cancer Institute Named Acting FDA Commissioner

0
Current commissioner, Scott Gottlieb, will be stepping down in April